Clinical Overview
Quetiapine is an atypical antipsychotic with a unique receptor profile, indicated for schizophrenia, bipolar disorder, and as adjunctive treatment for major depressive disorder. It has dose-dependent mechanisms with sedating antihistaminergic effects at low doses and antipsychotic effects at higher doses, making it versatile for multiple psychiatric conditions.
Primary Clinical Applications
Quetiapine is indicated for schizophrenia, acute manic episodes of bipolar I disorder, bipolar depression, maintenance treatment of bipolar disorder, and adjunctive treatment of major depressive disorder. At low doses (25-300 mg), it is commonly used off-label for insomnia due to its sedating properties.
Mechanism and Clinical Benefits
Quetiapine antagonizes dopamine D2, serotonin 5-HT2A, histamine H1, and alpha-1 adrenergic receptors. Its active metabolite norquetiapine acts as a norepinephrine reuptake inhibitor, which may contribute to its antidepressant effects. The dose-dependent receptor occupancy explains its varied clinical uses across different dose ranges.
Clinical Considerations
Quetiapine has significant metabolic side effects including weight gain, diabetes risk, and dyslipidemia, requiring regular monitoring. It can cause significant sedation, particularly during initiation. The extended-release formulation allows for once-daily dosing and may have improved tolerability. Cataracts have been reported in animal studies, prompting recommendations for periodic eye exams.
Prescribing Information
Dosing & Administration
Schizophrenia – Adults (Immediate Release):
- Day 1: 25 mg twice daily
- Day 2: 50 mg twice daily
- Day 3: 100 mg twice daily
- Day 4: 150 mg twice daily
- Target range: 300-400 mg daily in divided doses
- Maximum: 800 mg daily
Bipolar I Disorder – Acute Manic Episodes:
- Day 1: 100 mg daily in divided doses
- Day 2: 200 mg daily in divided doses
- Day 3: 300 mg daily in divided doses
- Day 4: 400 mg daily in divided doses
- Range: 400-800 mg daily
Bipolar Depression:
- Day 1: 50 mg at bedtime
- Day 2: 100 mg at bedtime
- Day 3: 200 mg at bedtime
- Day 4: 300 mg at bedtime (target dose)
Major Depressive Disorder (Adjunctive, XR):
- Days 1-2: 50 mg once daily in evening
- Day 3: 150 mg once daily in evening
- Target dose: 150-300 mg once daily
Administration:
- Immediate release: Divide into 2-3 doses daily
- Extended release: Once daily without food or with light meal
- XR tablets: Swallow whole, do not crush or chew
Indications
- Treatment of schizophrenia (adults and adolescents 13-17 years)
- Acute treatment of manic episodes of bipolar I disorder (adults and children 10-17 years)
- Acute treatment of depressive episodes associated with bipolar disorder
- Maintenance treatment of bipolar I disorder
- Adjunctive treatment of major depressive disorder (XR formulation)
Contraindications
- Known hypersensitivity to quetiapine or any component
- No absolute contraindications
Warnings & Precautions
- Boxed Warning: Increased mortality in elderly patients with dementia-related psychosis; increased suicidal thoughts in children, adolescents, and young adults (when used for depression)
- Metabolic changes: Significant risk of weight gain, diabetes, dyslipidemia
- Tardive dyskinesia: Risk with long-term use
- Neuroleptic malignant syndrome: Rare but serious risk
- Orthostatic hypotension: Particularly during dose initiation
- Cataracts: Periodic eye examinations recommended
- Thyroid function: Monitor TSH levels
Drug Interactions
- CYP3A4 inhibitors: Reduce quetiapine dose
- CYP3A4 inducers: May need to increase quetiapine dose
- CNS depressants: Enhanced sedation
- Antihypertensives: Enhanced hypotensive effects
Adverse Reactions
Common (≥5%):
- Somnolence, dizziness, dry mouth, constipation
- Weight gain, dyspepsia, orthostatic hypotension
Metabolic:
- Significant weight gain, hyperglycemia, dyslipidemia
Special Populations
- Hepatic Impairment: Start with 25 mg daily, increase by 25-50 mg daily
- Elderly: Increased mortality risk in dementia-related psychosis
- Pregnancy: Category C – use only if benefits outweigh risks
- Metabolic monitoring: Weight, glucose, lipids, blood pressure
Medical Disclaimer: This information is for educational purposes only and is not intended as medical advice. Always consult with qualified healthcare professionals before making any treatment decisions. Individual patient circumstances may vary significantly.
